NASDAQ:SIOX Sio Gene Therapies (SIOX) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free SIOX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.45▼$0.4850-Day Range$0.38▼$0.4852-Week Range$0.25▼$0.50Volume40,400 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisSocial MediaStock AnalysisSocial Media Get Sio Gene Therapies alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Sio Gene Therapies Stock (NASDAQ:SIOX)Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.Read More Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 SIOX Stock News HeadlinesFebruary 2, 2024 | finance.yahoo.comSio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareNovember 22, 2023 | morningstar.comSio Gene Therapies Inc SIOXApril 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…November 1, 2023 | thestreet.comTwo Promising Gene Therapy Stocks Tackling Eye DiseaseJuly 19, 2023 | fool.comSio Gene Therapies (NASDAQ: AXGT)July 13, 2023 | finance.yahoo.comRoivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 BillionMay 23, 2023 | nbcnews.comA new gene therapy could be a game-changer for patients with severe anemia. The cost? $2.8 million.February 14, 2023 | finance.yahoo.comSio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsApril 24, 2024 | True Market Insiders (Ad)Exposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…January 26, 2023 | seekingalpha.comSIOX Sio Gene Therapies Inc.December 14, 2022 | finance.yahoo.comSio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNovember 10, 2022 | bizjournals.comFollowing layoffs, gene therapy firm leaves DurhamNovember 10, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsOctober 31, 2022 | finance.yahoo.comSio Gene Therapies (NASDAQ:SIOX) Will Have To Spend Its Cash WiselyAugust 11, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsAugust 5, 2022 | uk.finance.yahoo.comSio Gene Therapies Inc. (SIOX)June 14, 2022 | bizjournals.comGene therapy firm in Durham slashes headcount as biotech stumblesJune 14, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsApril 28, 2022 | markets.businessinsider.comMid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares PlummetApril 28, 2022 | finance.yahoo.comSio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares PlungeApril 27, 2022 | finance.yahoo.comSio Gene Therapies Provides Corporate UpdateFebruary 11, 2022 | finance.yahoo.comSio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial ResultsFebruary 2, 2022 | benzinga.comSVB Leerink Downgrades Sio Gene Therapies to Market Perform, Lowers Price Target to $1February 1, 2022 | benzinga.comHC Wainwright & Co. Maintains Buy on Sio Gene Therapies, Lowers Price Target to $7February 1, 2022 | msn.comThe Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's ProgramJanuary 4, 2022 | nasdaq.comCompanies Like Sio Gene Therapies (NASDAQ:SIOX) Are In A Position To Invest In GrowthNovember 12, 2021 | finance.yahoo.comWe're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash WiselySee More Headlines Receive SIOX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/12/2021Today4/23/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SIOX CUSIPN/A CIK1636050 Websiogtx.com Phone(646) 677-6770FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNo Data Beta1.14 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. David W. Nassif J.D. (Age 70)CEO, CFO, Chief Accounting Officer, General Counsel & Director Comp: $699.52kKey CompetitorsContext TherapeuticsNASDAQ:CNTXGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPView All Competitors SIOX Stock Analysis - Frequently Asked Questions How were Sio Gene Therapies' earnings last quarter? Sio Gene Therapies Inc. (NASDAQ:SIOX) announced its quarterly earnings results on Friday, November, 12th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.17) by $0.12. When did Sio Gene Therapies' stock split? Sio Gene Therapies shares reverse split on the morning of Wednesday, May 8th 2019. The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. This page (NASDAQ:SIOX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sio Gene Therapies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
